Literature DB >> 25057949

Genetics and epigenetics of primary biliary cirrhosis.

Ilaria Bianchi1, Marco Carbone2, Ana Lleo1, Pietro Invernizzi1.   

Abstract

Primary biliary cirrhosis (PBC) has been considered a multifactorial autoimmune disease presumably arising from a combination of environmental and genetic factors, with genetic inheritance mostly suggested by familial occurrence and high concordance rate among monozygotic twins. In the last decade, genome-wide association studies, new data on sex chromosome defects and instabilities, and initial evidence on the role of epigenetic abnormalities have strengthened the crucial importance of genetic and epigenetic factors in determining the susceptibility of PBC. High-throughput genetic studies in particular have revolutionized the search for genetic influences on PBC and have the potential to be translated into clinical and therapeutic applications, although more biological knowledge on candidate genes is now needed. In this review, these recent discoveries will be critically summarized with particular focus on the possible steps that may transfer genetic and epigenetic knowledge to direct health benefits in patients with PBC. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25057949     DOI: 10.1055/s-0034-1383725

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  14 in total

Review 1.  Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics.

Authors:  Ji-Won Park; Jung-Hee Kim; Sung-Eun Kim; Jang Han Jung; Myoung-Kuk Jang; Sang-Hoon Park; Myung-Seok Lee; Hyoung-Su Kim; Ki Tae Suk; Dong Joon Kim
Journal:  Biomedicines       Date:  2022-05-31

2.  RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.

Authors:  Yan-Li Hao; Zhao-Lian Bian; Lin-Ling Ju; Yuan Liu; Gang Qin
Journal:  Dig Dis Sci       Date:  2019-08-03       Impact factor: 3.199

Review 3.  Genome-Wide Association Studies in Primary Biliary Cirrhosis.

Authors:  Aliya F Gulamhusein; Brian D Juran; Konstantinos N Lazaridis
Journal:  Semin Liver Dis       Date:  2015-12-16       Impact factor: 6.115

4.  DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis.

Authors:  Ana Lleo; Weici Zhang; Ming Zhao; Yixin Tan; Pietro Invernizzi; Qianjin Lu; M Eric Gershwin; Francesca Bernuzzi; Bochen Zhu; Qian Liu; Qiqun Tan; Federica Malinverno; Luca Valenti; Tingting Jiang; Lina Tan; Wei Liao; Ross Coppel; David H Adams
Journal:  Clin Epigenetics       Date:  2015-07-07       Impact factor: 6.551

Review 5.  Primary biliary cirrhosis is a generalized autoimmune epithelitis.

Authors:  Jun Gao; Liang Qiao; Bingyuan Wang
Journal:  Int J Mol Sci       Date:  2015-03-20       Impact factor: 5.923

6.  Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis.

Authors:  Ana Lleo; Zhaolian Bian; Haiyan Zhang; Qi Miao; Fang Yang; Yanshen Peng; Xiaoyu Chen; Ruqi Tang; Qixia Wang; Dekai Qiu; Jingyuan Fang; Cristina Sobacchi; Anna Villa; Luca Di Tommaso; Massimo Roncalli; M Eric Gershwin; Xiong Ma; Pietro Invernizzi
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

7.  Polymorphisms of IL12RB2 May Affect the Natural History of Primary Biliary Cholangitis: A Single Centre Study.

Authors:  Urszula Wasik; Ewa Wunsch; Gary L Norman; Eirini I Rigopoulou; Dimitrios P Bogdanos; Piotr Milkiewicz; Małgorzata Milkiewicz
Journal:  J Immunol Res       Date:  2017-02-19       Impact factor: 4.818

8.  A Common Variant in CLDN14 is Associated with Primary Biliary Cirrhosis and Bone Mineral Density.

Authors:  Ruqi Tang; Yiran Wei; Zhiqiang Li; Haoyan Chen; Qi Miao; Zhaolian Bian; Haiyan Zhang; Qixia Wang; Zhaoyue Wang; Min Lian; Fan Yang; Xiang Jiang; Yue Yang; Enling Li; Michael F Seldin; M Eric Gershwin; Wilson Liao; Yongyong Shi; Xiong Ma
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

9.  Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Authors:  Ulrich Beuers; M Eric Gershwin; Robert G Gish; Pietro Invernizzi; David E J Jones; Keith Lindor; Xiong Ma; Ian R Mackay; Albert Parés; Atsushi Tanaka; John M Vierling; Raoul Poupon
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

10.  NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid.

Authors:  Kathy L de Graaf; Geneviève Lapeyre; Florence Guilhot; Walter Ferlin; Stuart M Curbishley; Marco Carbone; Paul Richardson; Sulleman Moreea; C Anne McCune; Stephen D Ryder; Roger W Chapman; Annarosa Floreani; David E Jones; Cristina de Min; David H Adams; Pietro Invernizzi
Journal:  Hepatol Commun       Date:  2018-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.